[HTML][HTML] Current approaches and challenges in monitoring treatment responses in breast cancer

LJ Graham, MP Shupe, EJ Schneble, FL Flynt… - … of Cancer, 2014 - ncbi.nlm.nih.gov
monitoring treatment response in various clinical settings that are encountered in everyday
oncology practice. First, we will discuss monitoring for breast cancer … a third of breast cancer

Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype

CE Loo, ME Straver, S Rodenhuis, SH Muller… - Journal of Clinical …, 2011 - ascopubs.org
… associated with response could differ … for response monitoring. The purpose of our study
was to evaluate the relevance of breast cancer subtype on MRI markers of therapy response

Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic …

R Prevos, ML Smidt, VCG Tjan-Heijnen… - European …, 2012 - Springer
… It demonstrates that these kinds of large, homogeneous studies are required to further
investigate the true role of breast MRI in response monitoring of breast cancer patients receiving …

Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy

A Rieber, HJ Brambs, A Gabelmann, V Heilmann… - European …, 2002 - Springer
monitor response to preoperative chemotherapy with breast MRI in patients with large breast
cancer… had confirmed the presence of breast carcinoma underwent breast MRI prior to …

Role of positron emission tomography for the monitoring of response to therapy in breast cancer

O Humbert, A Cochet, B Coudert… - The …, 2015 - academic.oup.com
… ) tracers in the setting of response monitoring in breast cancer, with a special emphasis on
… of breast cancer, the metabolic response can predict the final complete pathologic response

[HTML][HTML] Chemotherapy-response monitoring of breast cancer patients using quantitative ultrasound-based intra-tumour heterogeneities

A Sadeghi-Naini, L Sannachi, H Tadayyon, WT Tran… - Scientific reports, 2017 - nature.com
… and monitor the pathological response of breast cancer to … monitor pathological response
and outcome of breast cancer … scatterers could predict treatment responses of patients with …

[HTML][HTML] FDG-PET/CT for response monitoring in metastatic breast cancer: the feasibility and benefits of applying PERCIST

M Vogsen, JL Bülow, L Ljungstrøm, HR Oltmann… - Diagnostics, 2021 - mdpi.com
… In this feasibility study, we found high applicability for PERCIST for longitudinal response
monitoring in metastatic breast cancer with 95% of patients having measurable disease …

Experimental validation of absolute SPECT/CT quantification for response monitoring in breast cancer

A Collarino, LM Pereira Arias‐Bouda… - Medical …, 2018 - Wiley Online Library
… study is to assess its quantitative accuracy for potential clinical 99m Tc‐sestamibi (MIBI)‐related
SPECT/CT application in neoadjuvant chemotherapy response studies in breast cancer. …

[HTML][HTML] Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features

L Sannachi, M Gangeh, H Tadayyon, A Sadeghi-Naini… - PloS one, 2018 - journals.plos.org
… This locally advanced breast tumor response monitoring study was approved by the
Sunnybrook Research Institute research ethics board. Ninety six locally advanced breast cancer

Response monitoring in metastatic breast Cancer: a prospective study comparing 18F-FDG PET/CT with conventional CT

M Vogsen, F Harbo, NM Jakobsen… - Journal of Nuclear …, 2023 - Soc Nuclear Med
… PET/CT for response monitoring in metastatic breast cancer using the standardized response
… Methods: Women with biopsy-verified metastatic breast cancer were enrolled prospectively …